Zenas Biopharma, Inc IPOs Tomorrow, Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Zenas BioPharma, Inc (NASDAQ:ZBIO) is set to IPO on September 13 on the NASDAQ, offering shares priced between $16.00 and $18.00. The company focuses on immunology-based therapies and has a 180-day insider lock-up period ending March 12, 2025.
September 12, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zenas BioPharma, Inc is launching its IPO on NASDAQ, with shares priced between $16.00 and $18.00. The company specializes in immunology-based therapies and has a 180-day insider lock-up period.
The IPO of Zenas BioPharma, Inc is a significant event as it marks the company's entry into the public market. The pricing range and the insider lock-up period are crucial details for investors. The focus on immunology-based therapies may attract interest from investors looking for growth in the biopharmaceutical sector.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100